These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38070973)

  • 1. [Closed-loop insulin therapy in type 1 diabetes after age 60].
    Bargain D; Campinos C
    Soins; 2023 Dec; 68(881):10-12. PubMed ID: 38070973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Patient Experience of Long-Term Hybrid Closed-Loop Insulin Pump Use.
    Wang LR; Malcolm J; Arnaout A; Humphrey-Murto S; LaDonna KA
    Can J Diabetes; 2021 Dec; 45(8):750-756.e3. PubMed ID: 33958309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes.
    Zaharieva DP; Messer LH; Paldus B; O'Neal DN; Maahs DM; Riddell MC
    Can J Diabetes; 2020 Dec; 44(8):740-749. PubMed ID: 33011134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
    Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
    Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.
    Majdpour D; Tsoukas MA; Yale JF; El Fathi A; Rutkowski J; Rene J; Garfield N; Legault L; Haidar A
    Can J Diabetes; 2021 Dec; 45(8):734-742. PubMed ID: 33888413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 7. Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.
    Boughton CK; Hartnell S; Lakshman R; Nwokolo M; Wilinska ME; Ware J; Allen JM; Evans ML; Hovorka R
    Diabetes Care; 2023 Nov; 46(11):1916-1922. PubMed ID: 37616583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training and Support for Hybrid Closed-Loop Therapy.
    Boughton CK; Hartnell S; Allen JM; Fuchs J; Hovorka R
    J Diabetes Sci Technol; 2022 Jan; 16(1):218-223. PubMed ID: 32914648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technologies and type 1 diabetes: what measures and effects in adolescents?].
    Bonnemaison É
    Soins Pediatr Pueric; 2021; 42(320):12-15. PubMed ID: 34099230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
    Benhamou PY; Franc S; Reznik Y; Thivolet C; Schaepelynck P; Renard E; Guerci B; Chaillous L; Lukas-Croisier C; Jeandidier N; Hanaire H; Borot S; Doron M; Jallon P; Xhaard I; Melki V; Meyer L; Delemer B; Guillouche M; Schoumacker-Ley L; Farret A; Raccah D; Lablanche S; Joubert M; Penfornis A; Charpentier G;
    Lancet Digit Health; 2019 May; 1(1):e17-e25. PubMed ID: 33323237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin pump therapy and continuous glucose monitoring].
    Schütz-Fuhrmann I; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Tauschmann M; Mader JK; Resl M; Kautzky-Willer A; Winhofer-Stöckl Y; Laimer M; Zlamal-Fortunat S; Weitgasser R
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):53-61. PubMed ID: 37101025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents' Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study.
    Rankin D; Kimbell B; Allen JM; Besser REJ; Boughton CK; Campbell F; Elleri D; Fuchs J; Ghatak A; Randell T; Thankamony A; Trevelyan N; Wilinska ME; Hovorka R; Lawton J
    J Diabetes Sci Technol; 2021 Sep; 15(5):1042-1051. PubMed ID: 34261348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closed-Loop Insulin Delivery Effects on Glycemia During Sleep and Sleep Quality in Older Adults with Type 1 Diabetes: Results from the ORACL Trial.
    Chakrabarti A; Trawley S; Kubilay E; Mohammad Alipoor A; Vogrin S; Fourlanos S; Lee MH; O'Neal DN; O'Regan NA; Sundararajan V; Ward GM; MacIsaac RJ; Colman PG; McAuley SA
    Diabetes Technol Ther; 2022 Sep; 24(9):666-671. PubMed ID: 35575751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.
    McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ
    Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid closed-loop system improves glycaemic control in young people with type 1 diabetes compared with conventional management.
    Holdstock V; Singh N
    Arch Dis Child Educ Pract Ed; 2023 Apr; 108(2):144. PubMed ID: 35606091
    [No Abstract]   [Full Text] [Related]  

  • 18. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial.
    Kubilay E; Trawley S; Ward GM; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; O'Neal DN; O'Regan NA; Sundararajan V; Vogrin S; Colman PG; McAuley SA
    Diabet Med; 2023 Apr; 40(4):e15020. PubMed ID: 36468784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technological innovations in the treatment of type 1 diabetes in pediatrics].
    Tubiana-Rufi N
    Soins Pediatr Pueric; 2016; (288):38-40. PubMed ID: 26776695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.